An investor asked on the investor interaction platform: Hello, secretary, before the festival, I saw that your 13 price pneumonia vaccine has passed the registration application in Morocco. In which countries has the vaccine applied for registration? Where is the specific progress? thank you
Walvax Biotechnology Co.Ltd(300142) (300142. SZ) said on the investor interaction platform on February 8 that at present, the registration of 13 valent pneumonia conjugate vaccine has been completed in Morocco, and the relevant export registration in other countries and regions is still under continuous communication. Please refer to the company’s announcement for specific progress.
